Zai Lab Ltd Business Operations Contracts & Agreements
7 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- Addendum to Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated June 30, 2024 (Filed With SEC on August 6, 2024)
- Collaboration and License Agreement by and between Seagen Inc. and Zai Lab (Hong Kong) Limited dated as of September 23, 2022 (Filed With SEC on November 9, 2022)
- License and Collaboration Agreement by and between Zai Lab (Shanghai) Co., Ltd. and Blueprint Medicines Corporation, dated November 8, 2021 (Filed With SEC on March 1, 2022)
- License and Collaboration Agreement, dated as of June 15, 2021, by and between Zai Lab (US) LLC and MacroGenics, Inc (Filed With SEC on August 9, 2021)
- Collaboration and License Agreement, dated as of May 28, 2021, by and between Zai Lab (Hong Kong) Limited and Mirati Therapeutics, Inc (Filed With SEC on August 9, 2021)
- Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated January 6, 2021 (Filed With SEC on May 10, 2021)
- Collaboration Agreement between Regeneron Ireland Designated Activity Company and Zai Lab (Shanghai) Co., Ltd. dated April 6, 2020 (Filed With SEC on March 1, 2021)
